AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
IPW vs IPSC Fundamental Comparison
| Metric | IPW | IPSC |
|---|---|---|
| Revenue | $19.2M | $109.2M |
| Net Income | $-1.7M | $-9.6M |
| Net Margin | -9.0% | -8.8% |
| ROE | -9.6% | -6.0% |
| ROA | -5.1% | -4.3% |
| Current Ratio | 1.83x | 5.97x |
| Debt/Equity | 0.02x | 0.07x |
| EPS | $-1.60 | $-0.14 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IPW vs IPSC: Frequently Asked Questions
Is IPW or IPSC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. IPW is rated SELL (78% confidence) while IPSC is rated SELL (78% confidence). This is not investment advice.
How does IPW compare to IPSC fundamentally?
iPower Inc. has ROE of -9.6% vs Century Therapeutics, Inc.'s -6.0%. Net margins are -9.0% vs -8.8% respectively.
Which stock pays higher dividends, IPW or IPSC?
IPW has a dividend yield of N/A or no dividend while IPSC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IPW or IPSC for long term?
For long-term investing, consider that IPW has SELL rating with 78% confidence, while IPSC has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IPW vs IPSC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IPW vs IPSC, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.